Clearside Biomedical, Inc. — Director's Dealing 2019

Feb 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2019-02-05

Reporting Person: Deignan Charles A. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-05	Employee Stock Option (right to buy)	$1.24	A	100000	Acquired	2029-02-05	Common Stock (100000)	Direct

Footnotes

F1: One-fourth of the shares underlying this option vest on February 5, 2020 and the balance of the shares vest in a series of 36 successive equal
monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.